Vir Biotechnology, Inc.·4

May 24, 2:33 PM ET

Sigal Charles Elliott 4

4 · Vir Biotechnology, Inc. · Filed May 24, 2023

Insider Transaction Report

Form 4
Period: 2023-05-22
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-22+12,05412,054 total
    Exercise: $25.74From: 2024-05-22Exp: 2033-05-21Common Stock (12,054 underlying)
  • Award

    Common Stock

    2023-05-22+6,02715,806 total
Holdings
  • Common Stock

    (indirect: See footnote)
    10,000
Footnotes (1)
  • [F1]By Sigal Family Investments, LLC

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT